Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weight-Based Torsemide vs Standard Care in Heart Failure
NCT03187509Phase 4Completed
- Sponsor
- NYC Health + Hospitals
- Start
- Apr 2018
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of torasemide in heart failure (HF), sponsored by NYC Health + Hospitals. Started Apr 2018; status: completed.
02
Drugs
torasemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03187509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03187509.